论文信息 - Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study) - 字舞流文

Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)

J. Sakamoto | S. Morita | T. Nagasaka | K. Hirata | H. Takemoto | K. Ishibashi | Y. Yoshida | H. Maeda | H. Mishima | S. Iwamoto | M. Imasato | Y. Munemoto | C. Tanaka | Atsushi Toyofuku | N. Nagata | A. Makiyama | Y. Morita | Y. Hotta